Monosymptomatic Enuresis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Children and adolescents aged 6 to 11 years, 11 months and 29 days with a diagnosis of primary NME; not receiving any enuresis treatment modality in the last 2 months; children and adolescents whose parents or guardians agreed to participate in the study, after reading, understanding and signing the Informed Consent Form (FICF) and Informed Consent Form.
Exclusion criteria
Exclusion criteria: Use of medication that changes the action of the detrusor muscle or external urethral sphincter; use of pacemaker; presence of polydipsia of any etiology;presence of moderate to severe intellectual disability of any nature identified by Raven's Progressive Matrices Test; families who refuse to attend the research clinic once a week - Children and adolescents diagnosed with primary NME and whose parents or guardians did not accept to participate in the study and/or did not sign an Informed Consent Form (FICF) and an Assent Term - Non-monosymptomatic or secondary enuresis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction in the number of dry nights, that is, nights without episodes of enuresis; evaluated by the calendar of dry nights; the result parameters are: No response = reduction in number of enuretic episodes <50% Partial response = 50% to 99% reduction in the number of enuretic episodes. Complete answer = no enuresis. This result will be verified immediately after the completion of the protocol (16th session) | — |
Secondary
| Measure | Time frame |
|---|---|
| Defined by the number of dry nights, ie nights without episodes of enuresis, verified in the dry nights calendar after 6 months of completion of the treatment protocol. The result parameters are: No response = reduction in number of enuretic episodes <50% Partial response = 50% to 99% reduction in the number of enuretic episodes. Complete answer = no enuresis | — |
Countries
Brazil